Light Therapy for Obsessive-compulsive Disorder (OCD)

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Washington University School of Medicine
Study ID
NCT06720090
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • OCD

Eligibility Criteria

Sex
ALL
Age
17 Years - 35 Years
Healthy Volunteers
Accepted

Interventions

  • Light therapy — BEHAVIORAL
    5 weeks of light therapy administered via wearable light therapy glasses worn for 1 hour each morning after awakening.

Study Details

The goal of this clinical trial is to test whether light therapy is effective for reducing symptoms in young adults with OCD and late bedtimes (1am or later). The main question\[s\] it aims to answer are: Does light therapy reduce OCD symptoms? Does light therapy advance the circadian clock? If there is a comparison group: Researchers will compare a higher dose of light therapy to a lower dose to see if dose amount affects symptom reduction. Participants will asked to: 1. Wear light therapy glasses for 1 hour each morning and complete a daily light therapy log for 5 weeks 2. Track their sleep every day with a wearable monitor and an electronic sleep diary for 5 weeks 3. Complete a 1-time assessment of sensitivity to light exposure 4. Complete self-report measures of OCD 4 times/day at baseline (2 weeks), mid-treatment (1 week), and end of treatment (1 week)

Key Dates

Start date
Dec 16, 2024
Status verified
Mar 2025
Primary completion
Mar 31, 2029
Completion
Mar 31, 2029

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Higher dose
    Participants will be given wearable light therapy devices that emit a higher light intensity.
  • Sham Comparator: Lower dose
    Participants will be given wearable light therapy devices that emit a lower light intensity.

Primary Outcome Measure

Yale Brown Obsessive-Compulsive Scale (YBOCS) [ Time Frame: Administered at baseline, in treatment week 3, and post-treatment (3 administrations over 7 weeks) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Washington UniversitySt LouisMissouri63130
Rebecca Cox, PhD
[email protected]
314-935-8111
Rebecca Cox (PRINCIPAL_INVESTIGATOR)

Find similar trials in St Louis, MO

By research site
Washington University· St Louis, MO

Related Studies